{"id":35736,"date":"2021-11-14T12:00:48","date_gmt":"2021-11-14T12:00:48","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=35736"},"modified":"2024-07-15T09:22:56","modified_gmt":"2024-07-15T09:22:56","slug":"pack-cross-linking-as-an-adjuvant-therapy","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/pack-cross-linking-as-an-adjuvant-therapy\/","title":{"rendered":"O PACK-CXL como terapia adjuvante melhora os resultados cl\u00ednicos na queratite"},"content":{"rendered":"

No tratamento da queratite infecciosa, a utiliza\u00e7\u00e3o do PACK-CXL como terapia adjuvante \u00e0 terapia antimicrobiana padr\u00e3o (SOC) melhora a situa\u00e7\u00e3o, em compara\u00e7\u00e3o com a SOC isolada, \u00e9 a mensagem a reter de um estudo publicado este m\u00eas na Cornea<\/em>.<\/p>\n

O PACK-CXL \u00e9 um m\u00e9todo bem estabelecido de tratamento de infec\u00e7\u00f5es da c\u00f3rnea, que consiste em saturar a regi\u00e3o da infe\u00e7\u00e3o com riboflavina (vitamina B2) e irradiar a \u00e1rea com luz ultravioleta (UV). A luz UV fotoactiva a riboflavina e provoca a gera\u00e7\u00e3o de esp\u00e9cies reactivas de oxig\u00e9nio (ROS), que t\u00eam v\u00e1rios efeitos ben\u00e9ficos. Em primeiro lugar, as ERO danificam diretamente as membranas celulares e os \u00e1cidos nucleicos dos agentes patog\u00e9nicos - um efeito antimicrobiano direto que \u00e9 totalmente independente dos medicamentos antimicrobianos convencionais. Os ERO tamb\u00e9m ligam de forma cruzada os tecidos da c\u00f3rnea, o que, atrav\u00e9s de um processo denominado impedimento est\u00e9rico, reduz o n\u00famero de locais de liga\u00e7\u00e3o enzim\u00e1tica para a a\u00e7\u00e3o das enzimas de digest\u00e3o de prote\u00ednas produzidas pelos agentes patog\u00e9nicos. Isto \u00e9 algo que reduz o tamanho da \u00falcera e, por conseguinte, o eventual tamanho da cicatriz da c\u00f3rnea. Se a \u00falcera, e depois a cicatriz, residir no centro da c\u00f3rnea do doente, a minimiza\u00e7\u00e3o do tamanho da cicatriz pode ter um impacto significativo na qualidade de vis\u00e3o final do doente.<\/p>\n

\"\"<\/a><\/p>\n

\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

Um cons\u00f3rcio multinacional de especialistas em c\u00f3rnea, abrangendo os Instituto ELZA<\/a> na Su\u00ed\u00e7a, no Egito e em Israel, propuseram-se realizar um estudo retrospetivo que comparou os efeitos do tratamento SOC e do PACK-CXL como adjuvante do tratamento SOC para \u00falceras da c\u00f3rnea causadas por uma infe\u00e7\u00e3o bacteriana em 47 olhos de 47 doentes, no tempo que demorou a tratar com \u00eaxito as \u00falceras da c\u00f3rnea e na acuidade visual final dos doentes.<\/p>\n

Os doentes (n=26) que receberam a terap\u00eautica PACK-CXL e SOC tiveram resultados significativamente melhores do que os doentes (n=21) que receberam apenas a terap\u00eautica SOC, em termos de melhor acuidade visual corrigida, tempo de reepiteliza\u00e7\u00e3o e nenhum doente necessitou de terap\u00eautica dupla enxertos tect\u00f3nicos<\/a> enquanto um ter\u00e7o dos doentes do grupo de terapia SOC isolada necessitaram destes enxertos.<\/p>\n

Os autores conclu\u00edram que \"Em conclus\u00e3o, demonstr\u00e1mos que o PACK-CXL \u00e9 seguro para utiliza\u00e7\u00e3o em casos de queratite bacteriana. Tamb\u00e9m parece acrescentar valor na redu\u00e7\u00e3o do tempo de cicatriza\u00e7\u00e3o e na melhoria da acuidade visual final, reduzindo a necessidade de queratoplastia tect\u00f3nica\".<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

Refer\u00eancia<\/strong><\/div>\n
<\/div>\n
Achiron A, Elhaddad O, Regev T, et al. A reticula\u00e7\u00e3o de pacotes como terapia adjuvante melhora os resultados cl\u00ednicos na queratite bacteriana confirmada por cultura. Cornea. Publicado online em 4 de novembro de 2021.<\/div>","protected":false},"excerpt":{"rendered":"

\"O PACK-CXL \u00e9 seguro para utiliza\u00e7\u00e3o em casos de queratite bacteriana. Parece tamb\u00e9m ter valor acrescentado na redu\u00e7\u00e3o do tempo de cicatriza\u00e7\u00e3o e na melhoria da acuidade visual final, reduzindo a necessidade de queratoplastia tect\u00f3nica\", observaram os autores do estudo.<\/p>","protected":false},"author":4,"featured_media":35739,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[214,95],"tags":[517,518,125,105,116,130,356,106],"class_list":["post-35736","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farhad-hafezi","category-scientific-article","tag-antimicrobials","tag-clinical-study","tag-cornea","tag-corneal-infection","tag-corneal-ulcer","tag-cross-linking","tag-infectious-keratitis","tag-keratitis"],"acf":[],"yoast_head":"\nPACK-CXL as an Adjuvant Therapy Improves Clinical Outcomes in Keratitis<\/title>\n<meta name=\"description\" content=\"PACK-CXL as an adjuvant to standard of care in bacterial keratitis improved final visual acuity and time to resolution compared with SOC.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/pack-cross-linking-as-an-adjuvant-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PACK-CXL as an Adjuvant Therapy Improves Clinical Outcomes in Keratitis\" \/>\n<meta property=\"og:description\" content=\"PACK-CXL as an adjuvant to standard of care in bacterial keratitis improved final visual acuity and time to resolution compared with SOC.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/pack-cross-linking-as-an-adjuvant-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-14T12:00:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-15T09:22:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/11\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/person\\\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"PACK-CXL as an Adjuvant Therapy Improves Clinical Outcomes in Keratitis\",\"datePublished\":\"2021-11-14T12:00:48+00:00\",\"dateModified\":\"2024-07-15T09:22:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/\"},\"wordCount\":387,\"publisher\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg\",\"keywords\":[\"antimicrobials\",\"clinical study\",\"Cornea\",\"Corneal infection\",\"Corneal ulcer\",\"Cross-Linking\",\"infectious keratitis\",\"Keratitis\"],\"articleSection\":[\"Farhad Hafezi\",\"Scientific article\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/\",\"name\":\"PACK-CXL as an Adjuvant Therapy Improves Clinical Outcomes in Keratitis\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg\",\"datePublished\":\"2021-11-14T12:00:48+00:00\",\"dateModified\":\"2024-07-15T09:22:56+00:00\",\"description\":\"PACK-CXL as an adjuvant to standard of care in bacterial keratitis improved final visual acuity and time to resolution compared with SOC.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg\",\"contentUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg\",\"width\":1200,\"height\":600,\"caption\":\"PACK CXL as an Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/pack-cross-linking-as-an-adjuvant-therapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.elza-institute.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farhad Hafezi\",\"item\":\"https:\\\/\\\/www.elza-institute.com\\\/farhad-hafezi\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"PACK-CXL as an Adjuvant Therapy Improves Clinical Outcomes in Keratitis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#website\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.elza-institute.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2016\\\/04\\\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2016\\\/04\\\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ELZA.Institute\\\/\",\"https:\\\/\\\/x.com\\\/ELZA_Institute\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/person\\\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/pt\\\/author\\\/markhillen\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"O PACK-CXL como terapia adjuvante melhora os resultados cl\u00ednicos na queratite","description":"O PACK-CXL como adjuvante do tratamento padr\u00e3o na queratite bacteriana melhorou a acuidade visual final e o tempo de resolu\u00e7\u00e3o em compara\u00e7\u00e3o com o SOC.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/pack-cross-linking-as-an-adjuvant-therapy\/","og_locale":"pt_PT","og_type":"article","og_title":"PACK-CXL as an Adjuvant Therapy Improves Clinical Outcomes in Keratitis","og_description":"PACK-CXL as an adjuvant to standard of care in bacterial keratitis improved final visual acuity and time to resolution compared with SOC.","og_url":"https:\/\/www.elza-institute.com\/pt\/pack-cross-linking-as-an-adjuvant-therapy\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2021-11-14T12:00:48+00:00","article_modified_time":"2024-07-15T09:22:56+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/11\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg","type":"image\/jpeg"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"PACK-CXL as an Adjuvant Therapy Improves Clinical Outcomes in Keratitis","datePublished":"2021-11-14T12:00:48+00:00","dateModified":"2024-07-15T09:22:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/"},"wordCount":387,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/11\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg","keywords":["antimicrobials","clinical study","Cornea","Corneal infection","Corneal ulcer","Cross-Linking","infectious keratitis","Keratitis"],"articleSection":["Farhad Hafezi","Scientific article"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/","url":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/","name":"O PACK-CXL como terapia adjuvante melhora os resultados cl\u00ednicos na queratite","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/11\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg","datePublished":"2021-11-14T12:00:48+00:00","dateModified":"2024-07-15T09:22:56+00:00","description":"O PACK-CXL como adjuvante do tratamento padr\u00e3o na queratite bacteriana melhorou a acuidade visual final e o tempo de resolu\u00e7\u00e3o em compara\u00e7\u00e3o com o SOC.","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/11\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/11\/PACK-Cross-Linking-as-Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis.jpg","width":1200,"height":600,"caption":"PACK CXL as an Adjuvant-Therapy-Improves-Clinical-Outcomes-in-Culture-Confirmed-Bacterial-Keratitis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/pack-cross-linking-as-an-adjuvant-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"Farhad Hafezi","item":"https:\/\/www.elza-institute.com\/farhad-hafezi\/"},{"@type":"ListItem","position":3,"name":"PACK-CXL as an Adjuvant Therapy Improves Clinical Outcomes in Keratitis"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/35736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=35736"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/35736\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/35739"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=35736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=35736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=35736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}